Utility of Melanin Degradation Products in the Nail for Diagnosing Nail Apparatus Melanoma

Tomoni Miyake; Akane Minagawa; Shosuke Ito; Yoshiharu Yokokawa; Kazumasa Wakamatsu; Ryuhei Okuyama

doi:10.2340/00015555-3757

Authors

Tomoni Miyake
Akane Minagawa Department of Dermatology, Shinshu University School of Medicine, 3908621 Matsumoto, Japan
Shosuke Ito
Yoshiharu Yokokawa
Kazumasa Wakamatsu
Ryuhei Okuyama

DOI:

https://doi.org/10.2340/00015555-3757

Keywords:

melanoma, nail streak, pyrrole-2,3,5-tricarboxylic acid, thiazole-2,4,5-tricarboxylic acid, 4-amino-3-hydroxyphenylalanine, biomarker

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Güne? P, Göktay F. Melanocytic lesions of the nail unit. Dermatopathology 2018; 5: 98-107.

DOI: https://doi.org/10.1159/000490557

Ito S, Nakanishi Y, Valenzuela RK, Brilliant MH, Kolbe L, Wakamatsu K. Usefulness of alkaline hydrogen peroxide oxidation to analyze eumelanin and pheomelanin in various tissue samples: application to chemical analysis of human hair melanins. Pigment Cell Melanoma Res 2011; 24: 605-613.

DOI: https://doi.org/10.1111/j.1755-148X.2011.00864.x

Wakamatsu K, Ito S, Rees JL. The usefulness of 4-amino-3-hydroxyphenylalanine as a specific marker of pheomelanin. Pigment Cell Melanoma Res 2002; 15: 225-232.

DOI: https://doi.org/10.1034/j.1600-0749.2002.02009.x

Del Bino S, Ito S, Sok J, et al. Chemical analysis of constitutive pigmentation of human epidermis reveals constant eumelanin to pheomelanin ratio. Pigment Cell Melanoma Res 2015; 28: 707-717.

DOI: https://doi.org/10.1111/pcmr.12410

Ohn J, Jo G, Cho Y, Sheu SL, Cho KH, Mun JH. Assessment of a predictive scoring model for dermoscopy of subungual melanoma in situ. JAMA Dermatol 2018; 154: 890-896.

DOI: https://doi.org/10.1001/jamadermatol.2018.1372

Kanda Y. Investigation of the freely-available easy-to-use software "EZR" (Easy R) for medical statistics. Bone Marrow Transplant 2013; 48: 452-458.

DOI: https://doi.org/10.1038/bmt.2012.244

Ito S, Wakamatsu K. Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. Pigment Cell Res 2003; 16: 523-531.

DOI: https://doi.org/10.1034/j.1600-0749.2003.00072.x

d'Ischia M, Wakamatsu K, Cicoira F, et al. Melanins and melanogenesis: from pigment cells to human health and technological applications. Pigment Cell Melanoma Res 2015; 28: 520-544.

DOI: https://doi.org/10.1111/pcmr.12393

Agrup G, Agrup P, Andersson T, et al. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis. Acta Derm Venereol 1979; 59: 381-388.

Wakamatsu K, Fukushima S, Minagawa A, et al. Significance of 5-S-cysteinyldopa as a marker for melanoma. Int J Mol Sci 2020; 21: 432.

DOI: https://doi.org/10.3390/ijms21020432

Omodaka T, Minagawa A, Uhara H, et al. Serum 5-S-cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients. J Dermatol 2018; 45: 1340-1344.

DOI: https://doi.org/10.1111/1346-8138.14605

Horikoshi T, Ito S, Wakamatsu K, Onodera H, Eguchi H. Evaluation of melanin-related metabolites as markers of melanoma progression. Cancer 1994; 73: 629-636.

DOI: https://doi.org/10.1002/1097-0142(19940201)73:3<629::AID-CNCR2820730321>3.0.CO;2-W

Hu DN, Wakamatsu K, Ito S, McCormick SA. Comparison of eumelanin and pheomelanin content between cultured uveal melanoma cells and normal uveal melanocytes. Melanoma Res 2009; 19: 75-79.

DOI: https://doi.org/10.1097/CMR.0b013e328329ae49

Wakamatsu K, Yokochi M, Naito A, Kageshita T, Ito S. Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients. Melanoma Res 2003; 13: 357-363.

DOI: https://doi.org/10.1097/00008390-200308000-00004

Wakamatsu K, Takasaki A, Kågedal B, Kageshita T, Ito S. Determination of eumelanin in human urine. Pigment Cell Res 2006; 19: 163-169.

DOI: https://doi.org/10.1111/j.1600-0749.2006.00296.x